Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?

Area of Science:

• Nephrology
• Cardiology
• Clinical Pharmacology

Background:

• Calcium supplementation poses risks for chronic kidney disease (CKD) patients, potentially leading to hypercalcemia and calcium overload.
• Impaired renal function exacerbates risks, increasing susceptibility to cardiac arrhythmias and arrest due to calcium imbalances.

Discussion:

• Even without overt hypercalcemia, calcium supplements can result in a positive calcium balance and intracellular overload in CKD patients.
• Hypercalcemia and calcium overload significantly elevate the risk of complex arrhythmias and cardiac arrest in individuals with compromised kidney function.

Key Insights:

• A cautious approach to calcium intake is crucial for CKD and hemodialysis patients.
• Recommendations suggest a maximum daily intake of 1000 mg of elemental calcium (dietary and supplemental).
• A dialysate calcium level of 1.5 mmol/l is proposed as a potentially safer option for CKD patients, particularly those with comorbidities.

Outlook:

• Further research is needed to establish optimal calcium management strategies for CKD patients.
• Individualized calcium dosing based on patient factors like extra-skeletal calcification and cardiac comorbidities is essential.
• Balancing the reduction of positive calcium balance with the risk of intradialytic arrhythmias requires careful consideration of dialysate calcium levels.